case_images: PMC8915120_01
case_images: PMC8915120_02
case_images: (A) Clinical history of the patient from 1994 to the end of the case study. *Therapeutic plan is slightly modified due to the patient's complaints of insomnia. #One of the antipsychotics used is discontinued due to the appearance of hyperprolactinemia. After stabilizing a hypomanic episode, olanzapine (oral) is substituted by aripiprazole (LAI), and therapy is readjusted to control insomnia. (B) Pharmacotherapy doses. Daily doses administered through the different stages of the patient clinical evolution. Mg, milligram; D, day.
case_images: fpsyt-12-830608-g0001.jpg
case_images: PMC8915120_02_fpsyt-12-830608-g0001.jpg
case_images: F1
case_images: For pharmacogenetic interactions (see Figure 1B).
case_images: PMC8915120_03
case_images: PMC8915120_04
case_images: PMC8915120_05
case_images: PMC8915120_06
case_images: PMC8915120_07
case_images: PMC8915120_08
case_images: PMC8915120_09